NCT00410761 2025-09-24An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerSanofiPhase 3 Completed331 enrolled 15 charts
NCT00390325 2024-02-06Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid CancerNational Cancer Institute (NCI)Phase 2 Completed21 enrolled 15 charts
NCT00358956 2017-01-30A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerSanofiPhase 2 Completed19 enrolled 10 charts